Elimination of symbiotic bacteria reduced lung adenocarcinoma development, as these bacteria promoted the proliferation and activation of Vγ6Vδ1 + γδ T cells, fostering inflammation through the production of effector molecules like IL-17, which in turn stimulates tumor cell proliferation (Jin et al., 2019). Here, IL17A is linked to lung adenocarcinoma.